Cannabidiol for psychotic disorders: A meta-analysis of randomized controlled trials
Published online on April 08, 2026
Abstract
Journal of Psychopharmacology, Ahead of Print.
Background:Cannabidiol (CBD) is being investigated as a novel antipsychotic treatment, but its effects on psychosis are mainly drawn from pre-clinical studies, leading to uncertainty about its clinical impact.Aims:To evaluate the efficacy and tolerability ...
Background:Cannabidiol (CBD) is being investigated as a novel antipsychotic treatment, but its effects on psychosis are mainly drawn from pre-clinical studies, leading to uncertainty about its clinical impact.Aims:To evaluate the efficacy and tolerability ...